Long considered maladies of affluent urban populations in mature Western economies, non communicable diseases (NCDs)– such as diabetes, cancer, chronic respiratory and cardiovascular diseases – have been spreading silently and…
In June 2017, PharmaBoardroom hosted an exclusive round table discussion with key players in Algerian healthcare on the role of health economics and patient data in health policy decision making.…
This chart shows how Algeria’s pharmaceuticals and healthcare system has evolved over time; from the creation of the Algerian Central Pharmacy (PCA) back in 1962, all the way to the…
As Egypt continues to grapple with the proliferation of the hepatitis C virus, fresh treatment, prevention and market access pathways are now being applied. Given the severity of Egypt’s hepatitis…
Concerted efforts are, at last, being made to redraw the rulebook and tidy up a local regulatory landscape long renowned for its torpor, dysfunction and ineffectuality. The Egyptian pharmaceutical market…
Trailing behind South Africa’s pharmaceutical market in both value and growth, the nation’s medical device industry has long enjoyed minimal barriers to entry and easy market access. But, with imminent…
The traditional model of healthcare has generally been limited to treatment in health facilities. But, when it comes to effectively treating more private and deeply personal health conditions, especially in…
Eclectic demographics, rapid patient recruitment, and a burgeoning population with a gradient of disease profiles—these seem to be the fundamentals truly driving growth in South Africa’s clinical trial industry. However,…
While South Africa faces a distinct set of challenges in effectively managing its healthcare sector, the ecosystem for innovation, particularly in the world of biotechnology remains fruitful. Bioentrepreneur Nick Duneas…
In an exclusive discussion with Focus Reports, Egyptian Minister of Health, Dr. Ahmed El Din Rady sets out his blueprint for improving the nation’s welfare and securing positive public health…
The Mauritian Government’s “Vision 2030” plan aims to transform the country into a high-income economy by 2030. The Healthcare and Life Science sector will play a key role in this transformation. Objective: To…
Looking for the right conditions to operate, an increasing number of foreign companies within the life sciences sector are looking at Mauritius as the ideal location to establish their headquarters.…
See our Cookie Privacy Policy Here